Peter A. Merkel
Update on outcome measure development in large-vessel vasculitis: Report from OMERACT 2018
Merkel, Peter A.; Mahr, Alfred; Direskeneli, Haner; Tugwell, Peter; Tómasson, Gunnar; Shea, Beverley; Milman, Nataliya; Meara, Alexa; Kermani, Tanaz A.; Hatemi, Gülen; Gul, Ahmet; Beard, Susan; Mackie, Sarah; Alibaz-Oner, Fatma; Aydin, Sibel Z.; Robson, Joanna Clare; Sreih, Antoine G.; Hill, Catherine
Tanaz A. Kermani
Sarah Mackie Sarah.Mackie@uwe.ac.uk
Faculty Lead on Practice-Oriented Curriculum
Sibel Z. Aydin
Jo Robson Jo.Robson@uwe.ac.uk
Consultant SL in Rheumatology
Antoine G. Sreih
The OMERACT Vasculitis Working Group seeks to develop validated outcome measures for use in trials for large-vessel vasculitis (LVV).
An international Delphi exercise conducted among investigators identified items considered important to measure active disease. In parallel, qualitative research with patients was conducted, including interviews and focus groups.
Next steps prioritized by the group for LVV include i) defining disease states (remission, flare, and patient-acceptable symptom state); and ii) selection of patient reported outcome tools.
The ultimate goal is to develop an OMERACT-endorsed Core Set of outcome measures for use in clinical trials of LVV.
|Journal Article Type||Article|
|Publication Date||Sep 1, 2019|
|Journal||The Journal of Rheumatology|
|Publisher||Journal of Rheumatology|
|Peer Reviewed||Peer Reviewed|
|APA6 Citation||Merkel, P. A., Direskeneli, H., Tugwell, P., Tómasson, G., Shea, B., Milman, N., …Hill, C. (2019). Update on outcome measure development in large-vessel vasculitis: Report from OMERACT 2018. Journal of Rheumatology, 46(9), 1198-1201. https://doi.org/10.3899/jrheum.181072|
|Additional Information||Additional Information : This is the author's accepted manuscript. The final published version is available here: https://doi.org/10.3899/jrheum.181072.|
LVV SIG OMERACT2018 Manuscript-20NOV2018_SZA (1).docx
LVV SIG OMERACT2018 Manuscript-20NOV2018_SZA %281%29.pdf
You might also like
The OMERACT emerging leaders program: The good, the bad, and the future